Switching to the aflibercept (3mg) therapy for treatment-resistant wet age-related macular degeneration: 1-year outcomes.
Autor: | Chengcheng Feng, Wenjuan Chu, Ping Lin, Haifeng Xu, Xiuli Chen |
---|---|
Zdroj: | Medicine; 4/19/2024, Vol. 103 Issue 16, p1-5, 5p |
Databáze: | Complementary Index |
Externí odkaz: |